Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Peritoneal Neoplasms × Letrozole × Clear all

Sponsor

Conditions

Breast Neoplasms 100 Neoplasm Metastasis 5 Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 4 Breast Neoplasms, Male 4 Arthralgia 4 Ovarian Neoplasms 3 Osteoporosis 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 2 Polycystic Ovary Syndrome 2 Pain 2 Leiomyosarcoma 2 Leiomyoma 2 Infertility 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Recurrence 1 Ovarian Cysts 1 Osteitis Deformans 1 Obesity 1 Multiple Endocrine Neoplasia Type 1 1 Medullary cystic kidney disease 1 1 Lymphoma, Non-Hodgkin 1 Lymphangioleiomyomatosis 1 Lethal Congenital Contracture Syndrome 2 1 Hormone-sensitive Metastatic Breast Cancer 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Fractures, Bone 1

Interventions

Paclitaxel 8 Carboplatin 6 Cisplatin 5 Hyperthermic Intraperitoneal Chemotherapy 4 Cytoreduction Surgical Procedures 3 Bevacizumab 3 nintedanib 2 Mitomycin 2 Gemcitabine 2 Fluorouracil 2 Docetaxel 2 vandetanib 1 talimogene laherparepvec 1 strattice 1 sodium thiosulfate 1 poly(I).poly(c12,U) 1 pembrolizumab 1 olaparib 1 liposomal doxorubicin 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 farletuzumab 1 enzastaurin 1 catumaxomab 1 birinapant 1 atezolizumab 1 alvimopan 1 Trabectedin 1 Topotecan 1 Surgical Procedures, Operative 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡